Answer
Combining ritlecitinib tosylate with systemic immunosuppressive medicines is not recommended because this combination has not been studied and a risk of additive immunosuppression cannot be excluded.
Sources for this answer
- Litfulo 50mg hard capsulesPfizer Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked